Key Insights

Highlights

Treatment Research

3 treatments under study, led by Polysomnographic Evaluation

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • Polysomnographic Evaluation1
  • Comparison Between Groups1
  • Magnetic Resonance1

Active Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Top Investigators

Activity Timeline